Article Text
Abstract
Introduction This study examines the use of remifentanil, an ultra-short-acting opioid, in emergency department (ED) patients.
Methods Chart review of ED patients receiving remifentanil for procedural sedation in an urban general ED.
Results 50 patients over a 28-month period with a mean age of 30.6 years (±2.6) were reviewed. Procedures performed included: abscess drainage (13); fracture care (9); thoracostomy (8); lumbar puncture (7); shoulder reduction (3); cardioversion (3) and others (7). Six (12%) cases received additional rescue medications. All procedures were successfully completed in the ED. No complications were recorded but 21 (42%) were admitted for underlying pathology.
Conclusion Remifentanil is a safe and effective medication for ED use.
- Analgesia pain control
- cardiac care
- emergency department
- paediatrics
- procedural sedation
- remifentanil
- ventilation
Statistics from Altmetric.com
Footnotes
-
Competing interests None.
-
Ethics approval This study was approved by the Institutional Review Board of Our Lady of Lourdes Medical Center, Camden, NJ, USA, which is the ethics committee for our institution.
-
Provenance and peer review Not commissioned; externally peer reviewed.
-
Data sharing statement If anyone is interested we will be glad to provide a blinded copy of the data base we used to collect the information for this study. To obtain this data please contact: Alfred Sacchetti at sacchetti1011@gmail.com.